TNFR1 negative allosteric modulators (Addex)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameTNFR1 negative allosteric modulators (Addex)
Drug Alias NameTNFR1 NAM
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor receptor superfamily member 1A modulators
TargetsTumor necrosis factor receptor superfamily member 1A
Therapy Area/IndicationsPsoriasisAlzheimer DiseaseMultiple Sclerosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAddex Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAddex Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsPsoriasisAlzheimer DiseaseMultiple Sclerosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A